Clinical-pregnancy outcome after vitrification of blastocysts produced from in vitro maturation cycles.
This study was conducted to report the clinical-pregnancy outcome after vitrification of the blastocysts produced from in vitro maturation cycles. The survival rate after thawing was 92.0% (92/100). The clinical-pregnancy and implantation rates were 43.8% and 23.6%, respectively. These results suggest that the blastocyst-stage embryos produced from in vitro maturation cycles can be safely cryopreserved through vitrification.
Lee
Seok-Yoon
SY
Maria Infertility Hospital, Seoul, Korea.
Son
Weon-Young
WY
Yoon
San-Hyun
SH
Lim
Jin-Ho
JH
D000328:Adult; D001755:Blastocyst / Q000166:cytology / Q000502:physiology*; D015925:Cryopreservation / Q000379:methods*; D004624:Embryo Transfer / Q000379:methods; D005260:Female; D005307:Fertilization in Vitro / Q000379:methods*; D006801:Humans; D007247:Infertility, Female / Q000628:therapy; D011247:Pregnancy; D011256:Pregnancy Outcome